Target intelligence / Profile preview

Low-density lipoprotein receptor family (LDLR family)

Target
LDLR family
Molecular classification
Receptor, Cell surface receptor, Endocytic receptor, Scavenger receptor (for certain family members)
01

Overview

The **Low-density lipoprotein receptor family** (often called apoE receptors) is a group of structurally related cell-surface receptors that bind apolipoprotein E (ApoE) and mediate endocytosis of various lipoprotein particles[5][3][7]. The most prominent member, the LDL receptor (LDLR), is critical for the clearance of cholesterol-rich lipoproteins in the liver and other tissues[5]. Family members, such as LDLR, LRP1 (low-density lipoprotein receptor-related protein 1), VLDLR (very-low-density lipoprotein receptor), and ApoER2 (LRP8), share structural motifs and overlapping ligand preferences[5]. ApoE-containing lipoproteins bind these receptors, which triggers endocytosis and delivery of lipids to cells, particularly hepatocytes and neurons[3][5][7]. In the central nervous system, these receptors are crucial for cholesterol transport from astrocytes to neurons, influencing synaptic function, neurodevelopment, and risk of neurodegenerative diseases such as Alzheimer’s disease[5][2][3]. Genetic variants or mutations affecting ApoE or its receptors can lead to lipid metabolism disorders, including familial hypercholesterolemia and type III hyperlipoproteinemia[3]. Receptor function is also involved in cardiovascular risk, and is a major target (directly or indirectly) of common lipid-lowering strategies such as statins and PCSK9 inhibitors. Ongoing research implicates these receptors in additional biological processes, such as immune regulation and brain repair mechanisms[5][7].

Other names
ApoE receptor familyLDL receptor familyLow-density lipoprotein receptor familyLipoprotein receptor familyLDLR familyLDLR, LRP1, VLDLR, ApoER2 (members)
02

Mechanism of action

Promote hepatic uptake of ApoE-containing lipoproteins by endocytosis - Modulation of receptor-ligand interactions for cholesterol clearance - Intracellular signaling affecting lipid and neuronal homeostasis- Some drugs increase receptor expression or function (e.g., statins, PCSK9 inhibitors), enhancing lipoprotein clearance

03

Biological functions

Lipoprotein endocytosis and clearanceCholesterol homeostasisLipid transportRegulation of neuronal cholesterol deliverySignal transduction (for some members, e.g., in neuronal function)Synaptic plasticity and neuroprotection (for CNS-expressed members)
04

Disease associations

Cardiovascular diseaseNeurodegenerative disease (notably Alzheimer’s disease)Lipid metabolism disorders (e.g., Type III hyperlipoproteinemia)AtherosclerosisOther dyslipidemias
05

Safety considerations

Over-modulation may cause hypocholesterolemia or unpredictable neurological consequencesSome ApoE receptor family members are widely expressed, so off-target effects are possibleGenetic variants (e.g., familial hypercholesterolemia due to LDLR mutations) can lead to variable efficacy and safety profilesModulation in the brain may affect synaptic function and cognitive outcomes
06

Interacting drugs

Statins (indirectly increase LDLR expression)

5 more in the full profile.

07

Biomarkers

Circulating LDL cholesterol (for LDLR function)ApoE genotype (ApoE4 allele as a risk marker for Alzheimer's)Lipoprotein particle levelsPlasma ApoE levelsCerebrospinal fluid cholesterol or ApoE-related measures in research settings

Beyond the preview

Go deeper on Low-density lipoprotein receptor family (LDLR family).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Low-density lipoprotein receptor family (LDLR family).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call